Journal article
Multiple sclerosis relapses: Epidemiology, outcomes and management. A systematic review
T Kalincik
Neuroepidemiology | KARGER | Published : 2015
DOI: 10.1159/000382130
Abstract
Relapses (episodic exacerbations of neurological signs or symptoms) are a defining feature of relapsing-remitting multiple sclerosis (MS), the most prevalent MS phenotype. While their diagnostic value relates predominantly to the definition of clinically definite MS, their prognostic value is determined by their relatively high associated risk of incomplete remission resulting in residual disability. The mechanisms governing a relapse incidence are unknown, but numerous modifiers of relapse risk have been described, including demographic and clinical characteristics, many of which represent opportunities for improved disease management. Also relapse phenotypes have been associated with patie..
View full abstractRelated Projects (2)
Grants
Funding Acknowledgements
Tomas Kalincik received research support from National Health and Medical Research Council (fellowship 1071124, project grant 1083539), Multiple Sclerosis Research Australia (fellowship 11-054) and University of Melbourne, and conference travel support and consultancy/speaker honoraria from Genzyme, Novartis, Biogen Idec, Sanofi Aventis, Teva, BioCSL and Merck Serono.